A Mechanistic Understanding of Reactive Oxygen Species (ROS)-Responsive Bio-Polymeric Nanoparticles: Current State, Challenges and Future Toward Precision Therapeutics
- PMID: 40370134
- DOI: 10.1002/bip.70027
A Mechanistic Understanding of Reactive Oxygen Species (ROS)-Responsive Bio-Polymeric Nanoparticles: Current State, Challenges and Future Toward Precision Therapeutics
Abstract
Inflammation is a hallmark of various pathological conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and autoimmune diseases. Reactive oxygen species (ROS) are crucial mediators in the inflammatory microenvironment, playing a pivotal role in both normal cellular processes and disease progression. Targeting ROS overproduction in inflamed tissues has emerged as a promising therapeutic strategy. Polymeric nanoparticles (NPs) responsive to ROS levels in pathological tissues have gained substantial attention as precision drug delivery systems, capable of ensuring controlled, site-specific drug release. This review provides a comprehensive mechanistic insight into ROS-responsive polymeric nanoparticles, examining their structural design, functionalization strategies, drug release mechanisms, and potential for targeted therapies in inflammatory conditions. Furthermore, we discuss recent advancements, challenges, and future directions in utilizing ROS-responsive polymeric nanoparticles for precision therapeutics, highlighting their transformative potential in clinical applications.
Keywords: drug delivery systems and precision therapeutics; inflammatory microenvironment; polymeric nanoparticles; reactive oxygen species (ROS).
© 2025 Wiley Periodicals LLC.
References
-
- M. Ahn, V. C. Chen, P. Rozario, et al., “Bat ASC2 Suppresses Inflammasomes and Ameliorates Inflammatory Diseases,” Cell 186, no. 10 (2023): 2144–2159.
-
- J. Liu, X. Han, T. Zhang, K. Tian, Z. Li, and F. Luo, “Reactive Oxygen Species (ROS) Scavenging Biomaterials for Anti‐Inflammatory Diseases: From Mechanism to Therapy,” Journal of Hematology & Oncology 16, no. 1 (2023): 116.
-
- H. D. Buzoglu, A. Burus, Y. Bayazıt, and M. Goldberg, “Stem Cell and Oxidative Stress‐Inflammation Cycle,” Current Stem Cell Research & Therapy 18, no. 5 (2023): 641–652.
-
- I. Z. Sadiq, “Free Radicals and Oxidative Stress: Signaling Mechanisms, Redox Basis for Human Diseases, and Cell Cycle Regulation,” Current Molecular Medicine 23, no. 1 (2023): 13–35.
-
- T. Chi, T. Sang, Y. Wang, and Z. Ye, “Cleavage and Noncleavage Chemistry in Reactive Oxygen Species (ROS)‐Responsive Materials for Smart Drug Delivery,” Bioconjugate Chemistry 35, no. 1 (2023): 1–21.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
